| The spread of CTX‐M‐type extended‐spectrum β‐lactamases GM Rossolini, MM D’andrea, C Mugnaioli Clinical Microbiology and Infection 14, 33-41, 2008 | 721 | 2008 |
| CTX-M-type β-lactamases: a successful story of antibiotic resistance MM D’Andrea, F Arena, L Pallecchi, GM Rossolini International Journal of Medical Microbiology 303 (6-7), 305-317, 2013 | 559 | 2013 |
| In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator A Cannatelli, MM D'Andrea, T Giani, V Di Pilato, F Arena, S Ambretti, ... Antimicrobial agents and chemotherapy 57 (11), 5521-5526, 2013 | 400 | 2013 |
| MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin A Cannatelli, T Giani, MM D'Andrea, V Di Pilato, F Arena, V Conte, ... Antimicrobial agents and chemotherapy 58 (10), 5696-5703, 2014 | 357 | 2014 |
| Multiple CTX-M-Type Extended-Spectrum β-Lactamases in Nosocomial Isolates of Enterobacteriaceae from a Hospital in Northern Italy L Pagani, E Dell'Amico, R Migliavacca, MM D'Andrea, E Giacobone, ... Journal of Clinical Microbiology 41 (9), 4264-4269, 2003 | 335 | 2003 |
| Characterization of poxtA, a novel phenicol–oxazolidinone–tetracycline resistance gene from an MRSA of clinical origin A Antonelli, MM D’Andrea, A Brenciani, CL Galeotti, G Morroni, S Pollini, ... Journal of Antimicrobial Chemotherapy 73 (7), 1763-1769, 2018 | 225 | 2018 |
| Emergence in Italy of Klebsiella pneumoniae Sequence Type 258 Producing KPC-3 Carbapenemase T Giani, MM D'Andrea, P Pecile, L Borgianni, P Nicoletti, F Tonelli, ... Journal of clinical microbiology 47 (11), 3793-3794, 2009 | 146 | 2009 |
| In Vivo Evolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin … A Cannatelli, V Di Pilato, T Giani, F Arena, S Ambretti, P Gaibani, ... Antimicrobial agents and chemotherapy 58 (8), 4399-4403, 2014 | 145 | 2014 |
| Characterization of pABVA01, a Plasmid Encoding the OXA-24 Carbapenemase from Italian Isolates of Acinetobacter baumannii MM D'Andrea, T Giani, S D'Arezzo, A Capone, N Petrosillo, P Visca, ... Antimicrobial agents and chemotherapy 53 (8), 3528-3533, 2009 | 116 | 2009 |
| Effects of selective digestive decontamination (SDD) on the gut resistome E Buelow, TB Gonzalez, D Versluis, EAN Oostdijk, LA Ogilvie, ... Journal of Antimicrobial Chemotherapy 69 (8), 2215-2223, 2014 | 113 | 2014 |
| CMY-16, a novel acquired AmpC-type β-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy MM D'Andrea, E Nucleo, F Luzzaro, T Giani, R Migliavacca, F Vailati, ... Antimicrobial agents and chemotherapy 50 (2), 618-624, 2006 | 87 | 2006 |
| Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe MM D'Andrea, E Literacka, A Zioga, T Giani, A Baraniak, J Fiett, E Sadowy, ... Antimicrobial agents and chemotherapy 55 (6), 2735-2742, 2011 | 85 | 2011 |
| Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases MM D'Andrea, C Venturelli, T Giani, F Arena, V Conte, P Bresciani, ... Journal of clinical microbiology 49 (7), 2755-2758, 2011 | 77 | 2011 |
| Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy ML Mezzatesta, MM D'Andrea, R Migliavacca, T Giani, F Gona, E Nucleo, ... Clinical microbiology and infection 18 (2), 160-166, 2012 | 76 | 2012 |
| Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology … T Giani, F Arena, S Pollini, V Di Pilato, MM D’Andrea, ... Journal of Antimicrobial Chemotherapy 73 (3), 664-671, 2018 | 75 | 2018 |
| Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II … V Conte, M Monaco, T Giani, F D'Ancona, ML Moro, F Arena, ... Journal of Antimicrobial Chemotherapy 71 (12), 3386-3391, 2016 | 72 | 2016 |
| Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type β-lactamase: epidemiology and clinical management F Luzzaro, G Brigante, MM D’Andrea, B Pini, T Giani, E Mantengoli, ... International journal of antimicrobial agents 33 (4), 328-333, 2009 | 72 | 2009 |
| φBO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage MM D’Andrea, P Marmo, L Henrici De Angelis, M Palmieri, N Ciacci, ... Scientific Reports 7 (1), 2614, 2017 | 62 | 2017 |
| Mining microbial metatranscriptomes for expression of antibiotic resistance genes under natural conditions D Versluis, MM D’Andrea, J Ramiro Garcia, MM Leimena, F Hugenholtz, ... Scientific reports 5 (1), 11981, 2015 | 61 | 2015 |
| Characterization of a multiresistance plasmid carrying the optrA and cfr resistance genes from an Enterococcus faecium clinical isolate G Morroni, A Brenciani, A Antonelli, M Maria D’Andrea, V Di Pilato, ... Frontiers in Microbiology 9, 391555, 2018 | 55 | 2018 |
Tommaso GianiUniversità di Firenze Dipartimento di Medicina Sperimentale e ClinicaVerified email at unisi.it
